Cargando…

Colistin and Carbapenem-Resistant Acinetobacter baumannii Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling

Resistance to the last-line antibiotics against invasive Gram-negative bacterial infection is a rising concern in public health. Multidrug resistant (MDR) Acinetobacter baumannii Aci46 can resist colistin and carbapenems with a minimum inhibitory concentration of 512 µg/mL as determined by microdilu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thadtapong, Nalumon, Chaturongakul, Soraya, Soodvilai, Sunhapas, Dubbs, Padungsri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468411/ https://www.ncbi.nlm.nih.gov/pubmed/34572636 http://dx.doi.org/10.3390/antibiotics10091054

Ejemplares similares

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
por: Oliveira, Priscila R., et al.
Publicado: (2020)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
por: Kon, Hadas, et al.
Publicado: (2023)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii
por: Sannio, Filomena, et al.
Publicado: (2022)

Is Aerosalization a Problem With Carbapenem-Resistant Acinetobacter baumannii in Thailand Hospital?
por: Apisarnthanarak, Anucha, et al.
Publicado: (2016)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022)

In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii
por: Oliva, Alessandra, et al.
Publicado: (2019)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
por: Percin, Duygu, et al.
Publicado: (2014)

Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital
por: Thet, Khin Thet, et al.
Publicado: (2020)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data
por: Oikonomou, O., et al.
Publicado: (2015)

First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt
por: Abdulzahra, Amani T., et al.
Publicado: (2018)

Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan
por: Ilsan, Noor Andryan, et al.
Publicado: (2021)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant Acinetobacter baumannii
por: Odabaş Köse, Elif, et al.
Publicado: (2023)

Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
por: Saelim, Weerayuth, et al.
Publicado: (2021)

Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing
por: Fam, Nevine S, et al.
Publicado: (2020)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Katip, Wasan, et al.
Publicado: (2021)

1111. Lack of Effectiveness of Colistin in Carbapenem-Resistant Acinetobacter baumannii : A Retrospective Single Center Cohort Study
por: Kim, Si-Ho, et al.
Publicado: (2023)

Whole-genome analysis of carbapenem-resistant Acinetobacter baumannii from clinical isolates in Southern Thailand
por: Chukamnerd, Arnon, et al.
Publicado: (2022)

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
por: Mu, Xinli, et al.
Publicado: (2016)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
por: Da Silva, Gabriela Jorge, et al.
Publicado: (2017)

Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii
por: Boinett, Christine J., et al.
Publicado: (2019)

The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii
por: Seleim, Shaimaa Mohamed, et al.
Publicado: (2022)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
por: Kabic, Jovana, et al.
Publicado: (2022)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations
por: Song, Joon Young, et al.
Publicado: (2015)

Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations
por: Ramadan, Raghdaa A, et al.
Publicado: (2018)

Phenotypic and Genotypic Investigation of Carbapenem-Resistant Acinetobacter baumannii in Maharaj Nakhon Si Thammarat Hospital, Thailand
por: Santajit, Sirijan, et al.
Publicado: (2023)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods
por: Rodjun, Vipavee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kskcpr1r72bld2gnr59dqn32l0